# Clinical Outcomes Following Toric Intraocular Lens Implantation: A Case Series Study

## TL;DR

This study shows that toric intraocular lenses effectively correct astigmatism and provide stable, precise vision outcomes after cataract surgery.

## Contribution

The study evaluates the performance of a specific toric intraocular lens model in real-world clinical settings.

## Key findings

- 94% of patients had postoperative residual astigmatism of 1.0 D or lower.
- 88% of implanted lenses remained within 5° of the intended axis.
- Most lenses showed counterclockwise rotation, with minimal impact on visual outcomes.

## Abstract

Purpose: This study aimed to assess the efficacy of for PODEYE TORIC intraocular lenses (IOL). Methods: This study was a retrospective, non-randomized, interventional case series. Inclusion criteria comprised diagnosis of an age-related cataract and a corneal astigmatism equal to or higher than 0.9 D and undergoing implantation of toric IOLs (TIOL). A single toric lens model (PodEye Toric, BVI) was used in all cases. Results: The study includes 51 eyes of 35 patients with TIOL implantation with a mean follow-up time of 45.7 (±36.5) days. Fourteen patients were targeted for mono-vision. Eight eyes had previously undergone refractive surgery (five post Myopic Lasik/PRK, two post RK/AK and one post RK). The mean postoperative adjusted spherical equivalent (SEQ) was −0.57 D ± 0.31 and the residual postoperative refractive astigmatism was −0.49 D ± 0.50. Only 2% of patients had a preoperative subjective astigmatism lower than 1.0 D whereas postoperatively, 94% of the patients had a residual astigmatism of 1.0 D or lower. The average deviation from the planned axis was 2.66 ± 0.26 degrees. None of the IOLs rotated to 10° or higher and 88% remained at 5° or less on the intended IOL axis. Twenty-six (63%) of IOL rotations were counterclockwise. Conclusions: PODEYE TORIC intraocular lenses provide exceptional refractive precision, reliable rotational stability, and consistently strong postoperative vision outcomes.